Key considerations for biosimilar use in managing bone health.
EP. 1: Optimizing Biosimilar Treatment Strategies in Bone Health
Colin C. Edgerton, MD, discusses key considerations for utilizing biosimilars in the bone health treatment landscape.
EP. 2: Managing Treatment Strategies for Osteoporosis Amid Evolving Biologic and Biosimilar Landscape
Jeffrey Curtis, MD, MS, MPH, provides expert perspective for navigating the evolving treatment landscape of osteoporosis and key considerations for biologic and biosimilar utilization.
